Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 150

Results For "TECH"

4015 News Found

Astellas and YASKAWA to establish JV focused on cell therapy manufacturing
News | March 10, 2025

Astellas and YASKAWA to establish JV focused on cell therapy manufacturing

Astellas stands on the forefront of healthcare change to turn innovative science into value for patients


Dr. Agarwals Eye Hospital inaugurates its third facility in Mysore
Healthcare | March 07, 2025

Dr. Agarwals Eye Hospital inaugurates its third facility in Mysore

This addition strengthens Dr. Agarwals Eye Hospital's vast network of 28 hospitals across Karnataka and 220+ facilities worldwide


Fermenta's plant-based Vitamin D3 is 'Innovation of the Year'
News | March 07, 2025

Fermenta's plant-based Vitamin D3 is 'Innovation of the Year'

VITADEETM Green is a 100% plant-based Vitamin D3 suitable for food & nutraceuticals


Biocon Biologics and Civica collaborate to expand Insulin Aspart access in US
News | March 07, 2025

Biocon Biologics and Civica collaborate to expand Insulin Aspart access in US

There are 38.4 million people with diabetes in the United States


Need for enhancing capacity building of medical officers to achieve desired results of healthcare schemes at the grassroot level: J. P. Nadda
Policy | March 05, 2025

Need for enhancing capacity building of medical officers to achieve desired results of healthcare schemes at the grassroot level: J. P. Nadda

Nadda also commended the role of ASHA workers, “grassroot foot soldiers”, in the healthcare system


Biocon Academy conducts 9th Graduation Day
News | March 04, 2025

Biocon Academy conducts 9th Graduation Day

Notably, 36 female students have been placed in Production and Manufacturing roles, reflecting the growing representation of women in core biotech operations


Venus Remedies secures firstiInternational market authorization for Sugammadex from the Philippines
Drug Approval | March 04, 2025

Venus Remedies secures firstiInternational market authorization for Sugammadex from the Philippines

The approval marks Venus Remedies’ strategic entry into complex generics, expanding its injectable portfolio beyond traditional formulations